id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-5468-0010,FDA,FDA-2024-N-5468,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:09:54Z,2025-23483,0,0,09000064b90f0498
FDA-2024-N-5468-0005,FDA,FDA-2024-N-5468,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration’s Adverse Event and Product Experience Reporting Program,Notice,30 Day Proposed Information Collection,2025-06-25T04:00:00Z,2025,6,2025-06-25T04:00:00Z,2025-07-26T03:59:59Z,2025-07-26T09:01:18Z,2025-11605,0,0,09000064b8e2dc26
FDA-2024-N-5468-0001,FDA,FDA-2024-N-5468,Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration’s Adverse Event and Product Experience Reporting Program,Notice,60 Day Proposed Information Collection,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,2025-03-19T03:59:59Z,2025-03-22T01:00:51Z,2025-01149,0,0,09000064868e2fb4